Welcome to Sequence Card of Peptide


Details of CancerPDF entry with Sequence RLAVYQAGAREGAER
Primary information
sequence IDSeq_6596
Peptide sequenceRLAVYQAGAREGAER
CancerPDF_ID CancerPDF_ID329, CancerPDF_ID1697, CancerPDF_ID2966,
PMID19795908,21136997,21136997
Protein NameApolipoprotein E,Apolipoprotein E,Apolipoprotein E
UniprotKB Entry NameAPOE_HUMAN,APOE_HUMAN,APOE_HUMAN
FluidPlasma,Serum,Plasma
M/Z549.6243333,1645.86485,1645.8648
Charge3,1,1
Mass (in Da)NA,NA,NA
fdrNA,NA,NA
Profiling TechniqueLC-MS,LC-MS,LC-MS
Peptide Identification techniqueMALDI-TOF/TOF,LC-MS-MS/MS,LC-MS-MS/MS
Quantification TechniqueLC-MRM (multiple reaction monitoring),LC-ESI-MS,LC-ESI-MS
Labelled/Label FreeLabelled,Label Free,Label Free
FDRless than 7%,NA,NA
CancerPDF_ID CancerPDF_ID329, CancerPDF_ID1697, CancerPDF_ID2966,
p-ValueNA,NA,NA
SoftwareFlexAnalysis 3.0 and Biotools 3.0 software,MASCOT(v. 2.2.01),MASCOT(v. 2.2.01)
Length15,15,15
Cancer TypeDuctal adenocarcinoma of the pancreas (DAP),Colorectal cancer,Normal
DatabaseNCBI refseq Protein Database,SwissProt Database,SwissProt Database
ModificationNA,NA,NA
Number of Patients"41 normal, 28 patients",30 patients and 30 healthy controls,27 healthy individuals
RegulationNA,NA,NA
ValidationNA,Leave One out Cross validation,Leave One out Cross validation
SensitivityNA,NA,NA
SpecificityNA,NA,NA
AccuracyNA,NA,NA
Peptide AtlasNA
IEDB